BUY Conviction3/5 Analysis quality60/100 Price target2.24 now
The YouTuber suggests Modus GI Holdings, a medical technology company focused on colorectal cancer detection. He highlights increasing revenue, a strong balance sheet with more cash than debt, and positive analyst ratings as reasons for potential growth.
“Modus GI has six analyst ratings here all either a buy or strong buy with an average analyst target of two dollars and 24 cents a share more than 157 percent above the current price.”